Semi‑random mutagenesis profile of BCR‑ABL during imatinib resistance acquirement in K562 cells
Overcoming imatinib resistance in chronic myelogenous leukemia cells using non-cytotoxic cell death modulators - ScienceDirect
Mechanisms of Resistance to Targeted Therapies in Chronic Myeloid Leukemia | SpringerLink
Part I: mechanisms of resistance to imatinib in chronic myeloid leukaemia. | Semantic Scholar
Deubiquitylation of Rab35 by USP32 promotes the transmission of imatinib resistance by enhancing exosome secretion in gastrointestinal stromal tumours | Oncogene
Imatinib Pathway, Pharmacokinetics/Pharmacodynamics
Frontiers | Combination Therapies in Chronic Myeloid Leukemia for Potential Treatment-Free Remission: Focus on Leukemia Stem Cells and Immune Modulation
Towards a Molecular Understanding of the Link between Imatinib Resistance and Kinase Conformational Dynamics | PLOS Computational Biology
Imatinib - Wikipedia
Mechanisms of resistance towards imatinib. (a) Imatinib is available... | Download Scientific Diagram
Targeting SOS1 overcomes imatinib resistance with BCR-ABL independence through uptake transporter SLC22A4 in CML: Molecular Therapy - Oncolytics
Imatinib resistance mechanisms. Imatinib resistance can be attributed... | Download Scientific Diagram
![PDF] Mechanisms of Resistance to Imatinib and Second-Generation Tyrosine Inhibitors in Chronic Myeloid Leukemia | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0a9b23d5cd08b70bab6df94e2948ce56a8452958/6-Figure1-1.png "PDF] Mechanisms of Resistance to Imatinib and Second-Generation Tyrosine Inhibitors in Chronic Myeloid Leukemia | Semantic Scholar")
PDF] Mechanisms of Resistance to Imatinib and Second-Generation Tyrosine Inhibitors in Chronic Myeloid Leukemia | Semantic Scholar
Adaptive phenotypic modulations lead to therapy resistance in chronic myeloid leukemia cells | PLOS ONE
Imatinib Resistance Mutation Analysis - Kinase Domain Test in Delhi | GDIC
Mechanisms of acquired resistance to tyrosine kinase inhibitors - ScienceDirect
Frontiers | BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia
Imatinib: Basic Results | Oncohema Key
5MJCB4-TKI
shRNA Loss-of-Function Screen Identifies Alternate Pathway for BCR-ABL - Cellecta
Imatinib resistance in chronic myeloid leukaemia caused by Bcr-Abl kinase domain and non-Bcr-Abl mutations: a comparison and review. | Australian Medical Student Journal
Mechanisms of Autoinhibition and STI-571/Imatinib Resistance Revealed by Mutagenesis of BCR-ABL: Cell
Response and Resistance to BCR-ABL1-Targeted Therapies
